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Background: Malaria is the leading cause of death worldwide. It is urgent to assess the impact of interventions and
scaled-up control efforts. Despite reported reduction in malaria prevalence in Africa, the trends in Cameroon are
not yet fully understood. The aim of this study was to investigate the trends in malaria admissions among febrile
patients seeking treatment over a seven-year period (2006–2012) in an endemic area in Cameroon, hypothesizing a
declining trend. This period followed changes in malaria treatment policy. The objectives were to identify possible
trends in malaria admissions and to evaluate the impact of changes to treatment guidelines on the prevalence.
Methods: Data was collected through consultation and perusal of laboratory and prescription registers of the
Mbakong Health Centre. Data analysis was conducted using SPSS and SAS Statistics.
Results: Analysis revealed that 4,230 febrile patients were received from 2006–2012. Of these febrile cases, 29.30%
were confirmed positive. Between 2006 and 2012 confirmed malaria positive cases of those tested fluctuated,
dropping from 53.21% in 2006 to 17.20% in 2008; then rising to 35.00% in 2011 and, finally, dropping to 18.2% of
those tested in 2012. The prevalence in females and males across all age groups were similar: a slightly higher risk
of males to have malaria (OR = 1.08, 95% CI 0.94-1.25) were not practically significant. Of those tested, the 5 to < 15 years
and the 1 to < 5 years age groups were the hardest hit by malaria in the area. A practically visible and significant
association was observed between the age and gender with regards to the number of malaria positive results
(Pearson ×2 = 153.675, p < 0.00001, Cramer’s V = 0.352). Malaria prevalence exhibited a fluctuating yet declining
trend, as observed over the 28 quarters between January, 2006 and December, 2012.
Conclusions: The changes to the treatment guidelines appear to result in a declining trend as was observed
between 2006 and 2008. However, malaria admissions fluctuated between 2008 and 2012. There is, therefore, a
need to step up control efforts of especially the vulnerable groups, such as the very young.
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Malaria is a complex disease that varies widely in epi-
demiology and clinical manifestations and remains the
leading cause of death in the world [1,2]. The 207 mil-
lion malaria cases reported globally in 2012 resulted in
an estimated 627,000 deaths with 80% of the cases in
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unless otherwise stated.child deaths in Africa [4]. The world malaria report of
2013 further revealed that between 2000 and 2012 the
malaria mortality among Africa children dropped by
54%. Malaria is endemic in Cameroon with a prevalence
rate of 29% [5]. It is the major cause of morbidity and
mortality among the most vulnerable groups: children
under five (18%), pregnant women (5%), people living
with HIV/AIDS (5.5%), and the poor (40%), the last of
which constitutes two thirds of the total population esti-
mated at 19 million [6]. Close to one million clinical cases
of malaria occur annually, accounting for more than 50%
morbidity among children under age five, 40 to 45% ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Ndong et al. Malaria Journal 2014, 13:328 Page 2 of 12
http://www.malariajournal.com/content/13/1/328medical consultations, and 30 to 47% of hospitalizations
[7]. In addition, it is responsible for 49% of prenatal con-
sultations and 59% of hospitalizations during pregnancy
leading to abortions, premature labour and deliveries and
low birth weight (LBW), thereby resulting in infant and
maternal mortality [8,9].
The epidemiologic profile of malaria in Cameroon ap-
pears to be aligned along three geographical and climatic
regions: i) an endemic and perennial transmission zone
covering the southern equatorial forest, coastal and
western plateau with 7–12 months of rainfall, ii) an en-
demic and seasonal transmission zone in the Adamawa
plateau and savannah forest with 4–6 months of rainfall
and iii) an epidemic and strongly seasonal zone covering
the Sudano-sahelian region with seasonal transmission
of 1–3 months [9,10].
The main methods for malaria diagnosis have been by
clinical diagnosis and microscopy until recently, when
rapid diagnostic test (RDTs) were introduced and the
Cameroon government rolled out RDTs in 2012 to im-
prove health facility diagnoses and home based manage-
ment of malaria. Microscopy as a testing service is widely
available (at 91% of public and 100% of private facilities),
but reportedly underused, with less than half of febrile pa-
tients tested for malaria during their consultation in some
countries in sub-Sahara Africa [5,11].
Over the last decade, the Cameroon government has
taken a series of steps to reduce the burden of malaria.
Owing to the development of resistance to various anti-
malarial drugs, the government adopted the WHO recom-
mendations of 2001 and changed the treatment policy
from chloroquine to artesunate-amodiaquine (ASAQ), as
the first-line treatment for uncomplicated malaria in 2004
and endorsed artemether-lumefantrine (AL) as an alter-
native artemisinin combination therapy (ACT) in 2006,
following alleged side-effects linked to ASAQ. Under
this new policy quinine and artemether injections are
reserved for cases of severe malaria, and sulphadoxine-
pyrimethamine for intermittent preventive treatment dur-
ing pregnancy [5,12-14].
Although the impact of interventions on malaria preva-
lence may differ from country to country [15], there is
mounting evidence across Africa that the increasing level
of malaria interventions have led to a reduction in malaria
prevalence from 37% in the years 1985–1999 to 17% in
2000–2007 and a consequent decline in morbidity and
mortality [16,17]. This has been brought about through
combining ACT and vector control using long-lasting
insecticidal nets (LLIN) [4]. In Rwanda, in-patient and
outpatient malaria cases in the under five age group de-
creased by 55% and 67% respectively and in Ethiopia by
73% and 62% following a nationwide distribution of LLIN
and artemisinin-based combination therapy (ACT). In
Cameroon there has been an overall reduction from41% in 2008, through 36% in 2010 to 31% in 2011 while
malaria related deaths reduced from 29% in 2009 to 19%
in 2011. In this country, free malaria treatment was
started for all children under five years of age in 2011.
In addition, community based management of malaria
using community relay agents was started and in 2012
more than eight million free mosquitoes nets were dis-
tributed to families nationwide [18-21]. The latter was a
scale up of the already existing programme of free mos-
quito net distribution to pregnant women and under
five children who visit antenatal clinics [22-24]. Maternal
mortality due to malaria also decreased from 5% in 2010
to 1% in 2011 [21]. This could lead to a change in the
transmission prolife of different zones [25]. Thus, the
WHO in 2010 recommended parasitological confirmation
of all malaria cases before treatment for patients five years
and above where testing services are available [26,27]. This
was geared towards reducing the unnecessary exposure to
anti-malarials.
If malaria prevalence is decreasing as a result of inter-
ventions, it is expected that the number of malaria positive
cases will decline in an area where such interventions
are taking place. Further investigations should also be
conducted to identify the proper course of treatment for
malaria negative febrile cases [28,29]. In addition, the
reduction in prevalence should be evident and significant
across different age groups, gender and over time. The
data analysed in this study spanned a seven-year period
(2006–2012). Malaria resurgence is known to follow a
five- to six-year epidemic cycle [30,31], which is most
probably an inherent characteristic of the disease itself
[32]. It is expected that interventions would have little to
no effect without knowledge of driving factors such as the
disease dynamics and the climate behind the cycle [33].
To some extent, knowledge of malaria prevalence trends
could be useful in planning, monitoring and evaluating
the level of implementation, or of interventions within a
given treatment policy over time, such as the one ongoing
in Cameroon. This could detect early warning signs of drug
resistance development, such as treatment failure or a sus-
tained upsurge in the number of malaria cases, despite re-
ceiving appropriate treatment. The objectives of this study
were, therefore, to identify possible trends in malaria preva-
lence over time and in terms of season; to assess differ-
ences in malaria prevalence across gender and age groups
and to evaluate the impact of changes to treatment guide-
lines on malaria prevalence. Furthermore, malaria drug re-
sistance is known to develop within an average of 10–15
years [34], and thus, seven years following the introduction
of ACT could be good time to investigate the trends.
The study is designed to understand the trends in mal-
aria admissions over the period 2006–2012 following the
change from chloroquine to ACT as first-line treatment
and the effect of supplementary interventions in this
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lower Bafut along the Mezam and Menchum Rivers near
the Menchum fall that has been earmarked for the gen-
eration of hydro-electricity. An in-depth understanding
of the malaria prevalence in patients seeking treatment
in this area will not only be of importance to the local
population, but for government to improve its planning
strategy for scaling up of malaria control programmes in
rural areas and the affluent population that would be
working on the dam or tourists visiting the Menchum
fall. It will provide baseline data for the prospective studies
on malaria prevalence in Cameroon.
Methods
Study site and population
The Mbakong Health Area consists of riverine communi-
ties with GPS coordinates 6°10’18.87” N and 10°05.40” E
with a head count of about 8,000 people. Mbakong falls
within the Bafut Heath District of the North West Region
of Cameroon (Figure 1). It lies within the Guinea Savannah
region at the border of the Bafut forest on the South and
the Bu forest to the north. It experiences a maximum rain-
fall pattern in August with a mean annual rainfall between
0 and 390 mm and a monthly temperature range of 22.49-
26.34°C. Mbakong has two distinct seasons – the dry and
the rainy season. The dry season starts from November to
March while the rainy season starts from March through
November. Human activities in this area include farming
(maize and rice), game hunting and sand mining from the
rivers. Sand mining is mainly carried out by young men
(above 15 years of age). The women and children are in-
volved in maize farming while all other members of the
community are involved in rice farming.
Study sample & data collection
Data was collected retrospectively through consultation
and perusal of laboratory and prescription registers of the
Mbakong Health Centre. Information was gathered on
diagnosis, age, gender and the time (months and years)
using operating procedures established for this study. The
data was classified into six different age groups: <1 year
(0–11 months), 1 to younger than five years (1 to <5), 5 to
younger than 15 years (5 to <15), 15 to younger than
45 years (15 to <45), 45 to younger than 65 years (45 to <65)
and 65 years and older (≥65). In this health facility micros-
copy was the only tool used for diagnosis. There was un-
fortunately no data on the environmental factors covering
the seven years considered in this study and thus there is
no attempt to assess the impact of environmental factors
such as rainfall or temperature on the prevalence.
Data analysis
Data analysis was conducted using SPSS Statistics V16.0
and SAS [35,36]. All clinical diagnoses for which laboratoryconfirmations were requested but the results were not ob-
tained were treated as missing data. Given that the sample
was not randomly selected and cannot be established as
representative of a larger population, the analyses focused
on the practical significance of findings even though stat-
istical significance is still reported [37]. Curve estimation
was used to evaluate the significance of trends in the data.
Pearson’s Chi Square test for relationship among variables
was used to evaluate the malaria prevalence across gender
and age groups. Finally, proportions and odds ratios were
evaluated with regards to statistical and practical signifi-
cance respectively.Ethical issues
The ethical clearance for this work was obtained from
the Ministry of Public Health and the Institutional Review
Board of the Catholic University of Cameroon, Bamenda.
In order to maintain anonymity, all patients were given
codes during the data extraction process and patient names
were not transcribed from the register.Results
The impact of changes to treatment guidelines on
malaria prevalence among febrile patients seeking
treatment
A total of 4,230 febrile patients sought treatment at the
Mbakong Integrated Health Centre and were clinically di-
agnosed to be suffering from malaria from 2006–2012.
Microscopy was conducted for 4,158 (98.30%) patients to
confirm the presence or absence of parasites. Of these,
1,239 (29.30%) were confirmed positives with 15 patients
per month on average. However, this number fluctuates
dramatically from month to month. Between 2006 and
2012 confirmed malaria positive cases (taken here as a
percentage of those tested) fluctuated, dropping steadily
from 356 (53.21%, 95% CI 0.49-0.57) in 2006 to 93
(17.20%, 95% CI 0.14-0.20) in 2008 and then gradually rose to
244 (35.00%, 95% CI 0.31-0.39) in 2011 and finally dropped to
91 (18.20%, 95% CI 0.15-0.22) in 2012 (Figure 2a).
Piecewise regression was used to identify any significant
change in prevalence when observed over the 84 months
spanning January 2006 to December 2012. Figure 2b indi-
cates an inflection point at January, 2008, corresponding
to the publication of new treatment guidelines. The first
regression line (Figure 2b line 1) was replicated using lin-
ear model via curve estimation and had an R2 value of
0.827, indicating a practically significant decline (gradient
was also statistically significant p < 0.001) in prevalence
(overall statistical significance p < 0.001) from 2006–2008.
The second regression line (Figure 2b line 2) was mod-
elled using the same methods. However, none of the
models were practically significant. These findings sug-
gest that the implementation of the new treatment
NFigure 1 The map of Cameroon showing the location of the study site.
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in malaria prevalence.
Trends in malaria prevalence among febrile patients over
time with reference to seasonal variation
The objective was to identify a possible seasonal trend
over a 12-month period. The data used was the propor-
tion of malaria positive cases of those tested observedfor each month over the seven-year period. As described
above, curve estimation was used to evaluate trend in
the data. Three models were applied to the data to evalu-
ated trends in the data over time, namely linear, quadratic
and the cubic models. While there are a multitude of
models that can be used to assess trends in the data over
time, those selected here were deemed the most inform-
































Figure 2 Distribution of malaria positive cases over seven years at the Mbakong Health Centre 2006–2012. a) Numbered dots indicate
when different interventions were introduced: 1) implemented change in malaria treatment policy from monotherapy to ACTs, 2) New treatment
guidelines made available to healthcare workers, 3) Nationwide distribution of 8 million LLIN and re-introduction of community management of
malaria, 4) Roll out of RDTs for testing before treatment both at the community and health facility level. b) Piecewise Regression of admissions
over months illustrating the change in prevalence from January 2006 to December 2012: Line 1 represents a sharp decline in malaria prevalence
from 2006–2008 and Line 2 represents a gradual rise in prevalence from 2008–2012.
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more appropriate model as well as to assess the goodness-
of-fit of all three models. The R2-values were also used to
assess the practical significance of trend with values above
0.5 indicative of a practically visible trend and values above
0.8 indicative of a practically significant trend [37]. Signifi-
cance testing, at the 5% confidence level, was also per-
formed to assess the overall significance of each model as
well as the model coefficients. Figure 3 illustrates the ab-
sence of a seasonal trend as none of the models were sta-
tistically or practically significant.
To conclude, no seasonal trend could be established in
the data. This is contrary to popular perception that
there is a major transmission season during the rainy
season between May and August and minor seasons be-
tween February to April and September to November. In
addition, the perception of a December-January spike,
in the heart of the dry season could be of interest since
the mosquito population at this time is very low and
consequently low malaria transmission. However, these
perceptions could not be verified in the data used for
this study. There is need to investigate further malariaFigure 3 Three models were used to investigate seasonal trend in ma
the curve estimation model. Both confirm the absence of a seasonal trendprevalence in asymptomatic individuals from December
through January in this area.
Curve estimation was again employed to identify pre-
defined trends over time. The data used was the propor-
tion of malaria positive cases to those tested observed
for each month over the seven-year period; 84 observa-
tions in total. Figure 4 illustrates the three models fitted
to the prevalence over time. All three models were sta-
tistically significant; however, only the cubic model ex-
plained sufficient variation to be of practical relevance
(R2 = 0.571, p<0.0001). The linear parameter of the
cubic model was both negative and significantly different
from zero (β=-0.042, p<0.0001). Proportions were also
calculated over the 28 quarters (each year is divided up
into four quarters of three months each) for the seven
year period. This was done to reduce some of the vari-
ation in the observed monthly data in an attempt to
identify trends. A cubic trend was found to be statisti-
cally significant and practically visible (R2 = 0.638,
p<0.0001) (Figure 5). The coefficient for the linear com-
ponent for the cubic model was significant as well as
negative (β= −0.132, p<0.001). Both the R2, as well aslaria occurrence. The graph shows monthly proportions fitted into
as none of the models were statistically or practically significant.
Figure 5 Graph illustrating the distribution of positive cases according to the quarters of the year over time using the curve
estimation model: Linear Quadratic, and Cubic? The cubic model was found to best fit the data with R2 = 0.638.
Figure 4 Graph illustrating the distribution of the proportion of positive cases according to the months of the year over time using
the curve estimation model (Linear Quadratic, and Cubic). The cubic model was found to best fit the data with R2 = 0.638. Time is divided
into 84 monthly observations and includes Jan. 2006 to Dec. 2012.
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modelled per quarter, which further established a fluctu-
ating yet declining trend.
Malaria prevalence among febrile patients across gender
and age groups
The distribution of confirmed malaria cases as a per-
centage of those tested was evaluated across gender and
age groups for the period 2006–2012. Malaria was found
to have a similar prevalence in females with 798 cases of
those tested (29.20%, 95% CI 0.28-0.31) and males with
441 of those tested (30.90%, 95% CI 0.29-0.33) across all
age groups. The males had a slightly higher risk of
contracting malaria than the females (OR = 1.08, 95% CI
0.94-1.25, p = 0.26) though it was not practically
significant.
The number of malaria confirmed cases of those tested
at the Mbakong health centre varied across different age
groups. In those tested, the age groups hardest hit by
malaria were the five to <15 years (296; 40.00%, 95% CI
0.36-0.44), 1 to <5 years (373; 38.26%, 95% CI 0.35-0.41)
and 15 to <45 years (411; 25.23%, 95% CI 0.23-0.27).
Prevalence was found to be low in the age groups youn-
ger than 1 year old children, 45 to <65 years and 65 years
or older patients with 400 (19.25%, 95% CI 0.15-0.23),
60 (19.481%, 95% CI 0.29-0.33) and 106 (20.76%, 95% CI
0.13-0.28), respectively. Overall, among the 1,239 patients
who tested positive for malaria, children younger than five
years of age constituted 36.30% while those younger than
15 years of age constituted 60.20% in Mbakong Health
Centre.
The distribution of malaria prevalence among febrile
patients across age was evaluated within each gender.
Evaluating whether the observed differences in age within
each gender are significant required grouping of the ages
into categories, similar to those used in categorizing
treatment regimes. Below 15 years of age, malaria preva-
lence was found to be similar between the male and the
female children with the respective proportions 35.4% and
35.14%, except for patients younger than one year where
the malaria admissions were found to be more in males
(23.76%) than females (14.64%). Above the age of 15 years
malaria prevalence was higher in the females (25.23%)
than the males (19.4%), except among the ≥65 year old pa-
tients where it was similar. The odds of having a positive
result for malaria was slightly higher in the males than in
the females for patients younger than one year (OR = 1.82,
95% CI 1.09-3.03 p = 0.02), 5 to <15 years (OR = 1.03, 95%
CI 0.77-1.39, p = 0.833) and ≥65 years (OR = 1.07, 95% CI
0.41-2.78, p = 0.98). It is worthy of note that odds ratios
were not statistically significant except for patients youn-
ger than one and none were of practical relevance [37].
In the age group 1 to <5 years and 15 to <45 years, the
risk of having malaria was higher in the femalescompared to the males (OR = 1.14, 95% CI 0.88-1.47, p =
0.33) and (OR = 1.29, 95% CI 0.95-1.75, p = 0.097), re-
spectively, without any practical significance. The females
in the age group 45 to <65 years had a higher risk of hav-
ing malaria than the males, which was both statistically
significant and practically visible (OR = 2.87, 95% CI 1.18-
7.01, p = 0.016).
The data revealed that from 2006 to 2008 malaria
prevalence among febrile patients decreased in all the
age groups. A drastic drop was witnessed in the following
age groups in the females: <1 year (from 54.55% in 2006
to 9.09% in 2008 and then to 0% in 2009) and 1 to <5 years
(75.56% in 2006 to 15.25% in 2008), while in the males it
dropped drastically in the following age groups: <1 year
(50.00% in 2006 to 15.25% in 2008), 1 to <5 year old
(60.87% in 2006 to 9.84% in 2008) and finally from 40
and 50% in 2006 respectively, in the age group 45 to <65
and ≥ 65 years group to 0% in 2008. Pearson’s product–
moment correlation coefficient was calculated to test the
association between prevalence and the ages (ungrouped)
of patients. The association was found to be both statisti-
cally as well as practically significant (r = −0.55; p < 0.001)
with lower levels of prevalence observed in older patients.
In 2008, malaria prevalence in febrile patients seeking
treatment was relatively higher in the females than males
while males maintained relatively higher prevalence from
2009 through 2012. From 2008 through 2011, the age
group 1 to <5 years and 5 to <14 year old children for
both genders observed an increase in prevalence. In
males the increase was from 9.84% in 2008 to 51.28%
in 2011 in the 1 to <5 year olds while in the 5 to <15 year
olds it increased from 20.56% in 2008 to 59.77% in 2011.
In the females the age group 1 to < 5 year old witnessed a
similar rise from 15.25% in 2008 to 45.83% in 2011 while
the 5 to <15 year old group witnessed a fluctuating rise
from 35.85% in 2008 to 50.00% in 2011. Following the
2008 drop in malaria, the age group 15 to <45 year old
has maintained a fluctuating but stable prevalence over
the last five years 2008–2012. From the analysis the age
groups 1 to <5 and 5 to <15 year old children seem to
have been the major affected age groups during the up-
surge in malaria prevalence witnessed in 2011 (Figure 6).
Pearson’s Chi Square test for degree of association was
used to investigate significant differences in prevalence
between years, months of each year, age groups and gen-
der (based on the number of malaria positive cases). The
test revealed a practically visible association between age
and gender (Pearson ×2 = 153.675, p < 0.001, Cramer’s
V = 0.352). A very weak association between year and age
(Pearson ×2 = 156.413, p < 0.001, Cramer’s V = 0.159) was
observed. No significant association was found between
month of the year and age (Pearson ×2 = 68.469, p = 0.105,
Cramer’s V = 0.105). A very weak association was found
between year and gender (Pearson ×2 = 13.085, p = 0.042,
Figure 6 Graphs depicting malaria prevalence as a proportion of those tested over the study period across different age groups from
2006–2012. The age group 1 to under 5 years and 5 to under 15 years old children are revealed to be the most affected across all the years and
were the hardest hit during the upsurge in 2011.
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tween gender and month of the year (Pearson ×2 = 5.510,
p = 0.94, Cramer’s = 0.067).
An analysis of the data revealed that 40/4230 (1.05%)
febrile patients returned for treatment within one month
of treatment for malaria at the Mbakong Health Centre
with 23 (57.5%) being males while 17 were females. Of
these 15 (37.5%) were <1 year infants (13 males and 2 fe-
males), 12 (30%) 15–49 years, 6 (15%) 15–14 years, 5
(12.5%) 1–4 years and 2 (5%) were 50–64 years. Twenty-
six (65%) of the returning patients were children ≤15 years.
The number of returning patients following treatment at
Mbakong witness a dropped from 11 (27.5%) in 2006 to
three (7.5%) in 2010 and 2011 and four (10%) in 2012. Of
all the returning cases only 17 (42.5%) tested positive for
malaria (nine females and eight males). Interestingly the
number of returning cases increased tremendously to 28
patients in 2013 (Additional file 1).
Discussion
Microscopy was well utilized at the Mbakong Health
Centre with 98.30% of cases tested for malaria. This dem-
onstrates an effective use of the testing tool at the level of
this health centre. This observation contrasts with earlier
reports that observed that microscopy was widely available
in public and private facilities, but underused, with less
than half of patients tested for malaria during their con-
sultation [5,11]. However, this conclusion is drawn from
an observation in one public facility and could deviatefrom this value as more facilities and different regions are
included.
The results of the present study have revealed a mal-
aria prevalence of 29.80% for tested febrile patients seek-
ing treatment within the study period 2006–2012 in the
Mbakong Health Area. The result tallied with an earlier
report of a clinical trial by Mangham and colleagues [5],
who observed that 29% of febrile outpatients that visit
either a public or private health facility or medicine retail
store were positive for malaria in Bamenda and Yaoundé.
This was further supported by a report that asymptomatic
pregnant women attending the Antenatal clinic in the
Bafut Health District revealed a malaria prevalence of
28.4% (Engochan Mbakwa, Ignatius Ndong, Wilfred
Mbacham and colleagues, 2014, personal communication).
The malaria prevalence among febrile patients seeking
treatment in Mbakong is lower than the 37% reported for
rural areas and higher than the 15% reported for the
North West region of Cameroon [20]. However, the mal-
aria prevalence in febrile patients observed in the study
was 10% lower than the 39.6% of confirmed malaria cases
reported in a similar study in Ethiopia [30]. The fluctuat-
ing patterns from 2006–2012 observed in this study were
very similar to those reported in studies in Ethiopia and
Rwanda [30,38] with a one-year lag period. While the low-
est and peak values in our study were observed in 2008
and 2011, respectively five years after the 2006 surge,
those in the Ethiopian study were observed in 2007 and
2010 respectively [30]. It is not clear what the influence of
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across the continent on the malaria cycle.
This observation closely ties in with five-year resurgence
cycle of malaria. No seasonal trends were observed. Over
time (taken as observations in month as well as quarters)
there was a significant and practically relevant fluctuating
but progressive decline in prevalence.
Since there was a significant association between the
gender, age groups and malaria positives cases, future re-
search will be required to investigate the possibility of
using age group and gender to predict the future outcome
of a patient tested for malaria in Mbakong and surround-
ing areas. However, substantial improvement seems to
have been achieved with the various interventions from
2006–2012. This can be seen from the fact that annual
malaria prevalence in febrile patients in 2011 was about
18% less than that of 2006 and though fluctuating, malaria
admissions appear to be on the decline at the Mbakong
Health centre [17].
The drop in malaria related admissions witnessed in
2012 coincides with the scaling up of the nationwide free
distribution of long lasting insecticide treated nets and
the roll out of RDT for community relay agents to con-
duct a confirmation test before treating for malaria by
the National Malaria Control Programme [23,24,39]. If
the latter had an effect, it seems to have been short-lived
as the prevalence gradually rose in the course of 2012.
This may point to the fact that the malaria prevalence in
the area follows its natural cycle despite the drug and in-
secticide pressure [32] or that the population were excited
and used the nets in the first few months and then re-
laxed. Alternatively, there may be a growing resistance to
the insecticides used on the nets [23,24,40-42]. However,
the impact of different interventions under the new policy
on the level of malaria, though not yet fully investigated,
cannot be under estimated. This can be seen from the
fact that prevalence level within the study period even
in the upsurge phase in 2011 never attained the 2006
levels. One of the setbacks in this study is the lack of
data before 2006 at the health centre, making compari-
son to pre-2006 prevalence impossible. However, the
2006 upsurge in prevalence observed in this study coin-
cides with those reported in a similar study in Ethiopia
and Rwanda [30,38] and seems to closely match the pe-
riods between 2000–2010 during which upsurge in mal-
aria mortality was observed in the systemic review by
Murray et al. [4].
Malaria prevalence in the febrile children under five
years of age is higher than those reported by Oladosu &
Oyibo [43] and Alemu et al. [30], but consistent with
similar findings in South Western Cameroon where
higher parasitaemia in asymptomatic children has been
reported [44]. Furthermore, the fact that children below
age 15 years constitute 60.2% of the total malariapositive cases detected in this health centre is in line
with earlier reports that children bear the greatest bur-
den of malaria in the world [45]. No clear pattern was
found in terms of gender and age groups but correlation
tests shows that as age increases, malaria prevalence
tends to decrease, corroborating an earlier finding in
Tanzania that malaria prevalence decreases with age
[46]. This could be a result of the partially acquired im-
munity cumulated with age and repeated infections with
the Plasmodium parasites [47]. While a declining trend in
prevalence was witnessed by all age groups from 2006–
2008, almost all the groups witnessed an upward trend
from 2009–2011 except the age group 15 to <45 years,
which maintained a fluctuating trend from 2009–2012.
Data analyses reveal that the upsurge in malaria preva-
lence observed in 2011 was due to a drastic increase in
prevalence in two age groups, 1 to <5 year and 5 to
<15 year old children. The exact cause of this is unclear.
These age groups fall within those with low partial im-
munity in an endemic area. The findings in this study sug-
gest that, amongst those tested, the most affected groups
are children and women. This result is in sharp contrast
with the report by Alemu et al. [30] where men where the
most affected. Although farming is the common denomin-
ator in the most affected groups in both studies, it is not
yet clear how this contributes to the high prevalence in
this young age group.
Though the odds of having positive results for malaria
alternated between males and females from one age group
to the other the effect size was small. Nevertheless, the
chances of having malaria were found to be generally
higher in the males than the females. However, females in
the age group 45 to <65 years had a significantly higher
risk of a positive malaria result. This was supported by a
practically visible effect (p = 0.026 OR = 2.87234).
Though there was dropped in the number of returning
cases treated for malaria at the Mbakong Health Centre
from 2006–2012 which could be attributed to various in-
terventions under the present policy. An interesting pic-
ture was observed in the high number of return cases in
2013, which was beyond this study period. Though 42.5%
of the returning febrile patients tested positive for malaria,
there is, however, no clue than this return rate of 1.05%
was due to treatment failure using ACT since there was
no patient follow up in this study. This could be a pointer
that there is need to monitor for treatment failure at this
health centre. This study acts as a baseline for future stud-
ies on the efficacy of ACT and other interventions.
Limitation of the study
The findings of this study are limited to the Mbkong
health centre and based on clinical and microscopic
diagnoses records of febrile patients considered retro-
spectively over a seven-year period 2006–2012. Prevalence
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fore this period were not available. Data on asymptomatic
malaria in adults is not captured in this study as it fo-
cuses on hospital records of essentially febrile patients
seeking treatment.Conclusions
The findings of this study reveal that the malaria admis-
sions in Mbakong have shown a fluctuating, but declining
trend over the last seven years with a practically relevant
significance. The Mbakong Health Centre seems to have
witnessed a significant decline in the malaria admissions
in the different age groups. Though it is not clear whether
the observed decline was due to the intervention under
the current policy or part of the natural cycle of malaria,
the impact of the new treatment policy cannot be under
estimated. There is need for control efforts to be stepped
up and for establishing a monitoring scheme with specific
reference to the vulnerable groups.
One of the cyclic phases of the malaria disease with a
declining trend seems to have been witnessed within this
seven year period of 2006–2012. However, the study
period needs to be extended and the number of facilities
increased for meaningful conclusions to be drawn. Never-
theless, this study provides a baseline for malaria prevalence
studies to be conducted in this area in future.Additional file
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